DC Field | Value | Language |
---|---|---|
dc.contributor.author | Paik, Hyo-Jung | ko |
dc.contributor.author | Lee, Eun-Jung | ko |
dc.contributor.author | Lee, Do-Heon | ko |
dc.date.accessioned | 2013-03-11T17:29:12Z | - |
dc.date.available | 2013-03-11T17:29:12Z | - |
dc.date.created | 2012-02-06 | - |
dc.date.created | 2012-02-06 | - |
dc.date.issued | 2010-12 | - |
dc.identifier.citation | BMB REPORTS, v.43, no.12, pp.836 - 841 | - |
dc.identifier.issn | 1976-6696 | - |
dc.identifier.uri | http://hdl.handle.net/10203/99735 | - |
dc.description.abstract | In the era of personal genomics, predicting the individual response to drug-treatment is a challenge of biomedical research. The aim of this study was to validate whether interaction information between genetic and transcriptional signatures are promising features to predict a drug response. Because drug resistance/susceptibilities result from the complex associations of genetic and transcriptional activities, we predicted the inter-relationships between genetic and transcriptional signatures. With this concept, captured genetic polymorphisms and transcriptional profiles were prepared in cancer samples. By splitting ninety-nine samples into a trial set (n = 30) and a test set (n = 69), the outperformance of relationship-focused model (0.84 of area under the curve in trial set, P = 2.90 x 10(4)) was presented in the trial set and validated in the test set, respectively. The prediction results of modeling show that considering the relationships between genetic and transcriptional features is an effective approach to determine outcome predictions of drug-treatment [BMB reports 2010; 43(12): 836-841] | - |
dc.language | English | - |
dc.publisher | KOREAN SOCIETY BIOCHEMISTRY MOLECULAR BIOLOGY | - |
dc.subject | OVARIAN-CANCER | - |
dc.subject | PACLITAXEL CHEMOTHERAPY | - |
dc.subject | CELL-LINES | - |
dc.subject | IN-VITRO | - |
dc.subject | EXPRESSION | - |
dc.subject | RESISTANCE | - |
dc.subject | MULTIDRUG | - |
dc.subject | APOPTOSIS | - |
dc.title | Relationships between genetic polymorphisms and transcriptional profiles for outcome prediction in anticancer agent treatment | - |
dc.type | Article | - |
dc.identifier.wosid | 000285816300011 | - |
dc.identifier.scopusid | 2-s2.0-78650687164 | - |
dc.type.rims | ART | - |
dc.citation.volume | 43 | - |
dc.citation.issue | 12 | - |
dc.citation.beginningpage | 836 | - |
dc.citation.endingpage | 841 | - |
dc.citation.publicationname | BMB REPORTS | - |
dc.identifier.doi | 10.5483/BMBRep.2010.43.12.836 | - |
dc.contributor.localauthor | Lee, Do-Heon | - |
dc.contributor.nonIdAuthor | Lee, Eun-Jung | - |
dc.description.isOpenAccess | Y | - |
dc.type.journalArticle | Article | - |
dc.subject.keywordAuthor | Anticancer agents | - |
dc.subject.keywordAuthor | Drug response | - |
dc.subject.keywordAuthor | Individual variation | - |
dc.subject.keywordAuthor | Prediction model | - |
dc.subject.keywordAuthor | Relationship | - |
dc.subject.keywordPlus | OVARIAN-CANCER | - |
dc.subject.keywordPlus | PACLITAXEL CHEMOTHERAPY | - |
dc.subject.keywordPlus | CELL-LINES | - |
dc.subject.keywordPlus | IN-VITRO | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | RESISTANCE | - |
dc.subject.keywordPlus | MULTIDRUG | - |
dc.subject.keywordPlus | APOPTOSIS | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.